Prévention de la thrombose et de l'inflammation vasculaire : place des inhibiteurs mixtes des cyclooxygénases et de la 5-lipoxygénase

Thus, platelet-leukocyte interactions which dominate the underlying inflammatory process particularly in atherosclerosis, might reinforce the benefits of such inhibitors. (J Mal Vasc 2006; 31: 4-9).